CA74449F1009 - Common Stock
PSYENCE BIOMEDICAL LTD
NASDAQ:PBM (7/26/2024, 5:40:06 PM)
After market: 0.55 -0.03 (-5.17%)0.58
-0.02 (-3.33%)
Psyence Biomedical Ltd. is a life science biotechnology company. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
PSYENCE BIOMEDICAL LTD
121 Richmond Street West Penthouse, Suite 1300
TORONTO ONTARIO V6E 3Z3
P: 17744604171
CEO: John Plourde
Employees: 0
Website: http://psyence.com
Friday's after hours session: top gainers and losers
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
These stocks are moving in today's session
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Here you can normally see the latest stock twits on PBM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: